Microwave assisted synthesis and antimicrobial activity of some novel Isonicotinoyl-Pyrazol derivatives

International Journal of ChemTech Research

Volumn 2, Issue 3, 2010, Pages 1454-1460

  Parashar, Bharat ^a   Bharadwaj, Sudhir ^b   Sahu, Amit ^c   Sharma, V K ^d   Punjabi, P B ^d  

^a Geetanjali College of Pharmaceutical Studies   (India)

^b Institute of Professional Studies   (India)

^c Techno India NJR Institute of Technology   (India)

^d M L SUKHADIA UNIVERSITY   (India)

Author keywords

Ethyl 2 cyanoacetate and Furan 2 carbaldehyde; Isonicotinohydrazide; Microwave

Indexed keywords

3 (2 HYDROXYBENZYLIDENEAMINO) 1 ISONICOTINOYL 1H PYRAZOL 5 (4H)ONE; 3 (3 HYDROXYBENZYLIDENEAMINO) 1 ISONICOTINOYL 1H PYRAZOL 5 (4H)ONE; 3 (4 CHLOROBENZYLIDENEAMINO) 1 ISONICOTINOYL 1H PYRAZOL 5 (4H)ONE; 3 (4 FLUOROBENZYLIDENEAMINO) 1 ISONICOTINOYL 1H PYRAZOL 5 (4H)ONE; 3 (4 HYDROXYBENZYLIDENEAMINO) 1 ISONICOTINOYL 1H PYRAZOL 5 (4H)ONE; 3 (4 METHOXYBENZYLIDENEAMINO) 1 ISONICOTINOYL 1H PYRAZOL 5 (4H)ONE; 3 (4 NITROBENZYLIDENEAMINO) 1 ISONICOTINOYL 1H PYRAZOL 5 (4H)ONE; 3 (BENZYLIDENEAMINO) 1 ISONICOTINOYL 1H PYRAZOL 5 (4H)ONE; 3 (FURAN 2 YLMETHYLENEAMINO) 11 ISONICOTINOYL 1H PYRAZOL 5 (4H)ONE; 3 AMINO 1 ISONICOTINOYL 1H PYRAZOL 5 (4H)ONE; ACETIC ACID DERIVATIVE; BENZALDEHYDE DERIVATIVE; CHLORINE; ETHYL 2 CYANOACETATE; FLUORINE; HETEROCYCLIC COMPOUND; HYDROXYL GROUP; ISONIAZID; NITRIC OXIDE; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG SYNTHESIS; ESCHERICHIA COLI; FUNGUS; MICROWAVE IRRADIATION; NONHUMAN; POLYMERIZATION; PROGENY; PSEUDOMONAS AERUGINOSA; SPECTROSCOPY; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

EID: 77957339264     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Govt. of India, Ministry of Health and Family Welfare; Indian Pharmacopoea Controller of Publication: Delhi, 1996, 408.
2. McNeill, L.; Allen, M.; Estrada, C.; Cook, P. Chest, 2003, 123(1), 102.
3. Jasmer, R. M.; Sankonnen, J. J.; Blumberg, H. M.; Daley, C. L.; Bemardo, J.; Vittinaghoff, E.; King, M. D.; Dawamura, L. M.; Hopewell, P. C. Ann. Intern. Med., 2002, 137, 640.
4. World Health Organization: Geneva; WHO Global Tuberculosis Programme, 1997.
5. Alagarasamy, V.; Venkateshperumal, R.; Sathyabhama, S.; Vaishnavapriya, S.; Sakkarapandi, S.; Revathi, V.; Kalaiselvi, R.; Balamurugan, J.; Sevukarajan, M. Indian J. Heterocycl. Chem., 2002, 11, 327.
6. Lewis, R. The Rise of Antibiotic-Resistant Infections, FDA consumer magazine, Sept., 1995.
7. El-Kashef, H.; El-Emary, T.; Gasquet, M.; Timon-David, P.; Maldonado, J.; Vanello, P. Pharmazie, 2000, 55, 572.
8. Taha, M.; Moukha-Chafiq, O.; Lazrok, H.; Vasseur, J.; Imbach, J. Nucleosides Nucleotides Nucleic Acids, 2001, 20, 955.
9. Vicentini, C.; Forlani, G.; Manfrini, M.; Romagnoli, C.; Mares, D. J. Agric. Food Chem., 2002, 55, 4839.
10. Brozozonski, Z.; Saczawski, F. Eur. J. Med. Chem., 2002, 37, 709.
11. Hough, L.; Nalwalk, J.; Stadel, R.; Timmerman, H.; Leurs, R.; Paria, B.; Wang, X.; Dey, S J. Pharmacol. Ex. Ther., 2002, 303, 14.
12. Barry, AL.The Antimicrobial Susceptibility Test: Principal and Practices Philadephia, Pa, U.S.A. 1976.
13. Ochei, J.; Kolhatkar, A.Medicinal Laboratory Science-Theory and Practices. Tata McGrow-Hill Publishing Co. Ltd. New Delhi, (2000).